Phase II study of concurrent carboplatin, pemetrexed, and radiotherapy for limited stage of small cell lung cancer.

Trial Profile

Phase II study of concurrent carboplatin, pemetrexed, and radiotherapy for limited stage of small cell lung cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Oct 2013

At a glance

  • Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
  • Indications Small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 17 Dec 2009 Actual end date (October 2008) added as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Actual patient number (4) added as reported by ClinicalTrials.gov.
    • 28 Jan 2008 Status change from recruiting to discontinued as reported by clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top